changing from tirzepatide to retatrutide How Switch To Retatrutide: A Triple Agonist Shaping
Description
More than half of patients (54.8%) had type 2 diabetes
Tirzepatide produced a larger absolute reduction in 10year CVD risk than semaglutide (about 2.4% vs
R., Bizhanova, Z., et al
"People should always work their physician to determine what works for them based on their history," Novo Nordisk says in a statement when asked about this issue
Clinical trials have shown that participants can lose 15 to 20 percent of their initial body weight over just 72 weeks
Overseen by Megan, DNP, MSN
